The content on this site is intended for healthcare professionals only
Prof Andrew Chan speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the use of antithrombotic drugs to reduce the risk of gastrointestinal (GI) bleeding.
He discusses the current development of risk scores that aim to identify patients who are at high risk of GI bleeding.
Prof Chan emphasises that it is important to convey the preventative effects of aspirin versus the side effects to patients to help them make an informed decision.
He also believes there is good evidence to suggest the use of additional medications alongside aspirin to reduce the risk of bleeding, particularly in the high-risk population.
Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.
Treatment management of favourable risk and very favourable risk patients
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
The parotid gland; an unusual site of colorectal cancer metastasis
Choosing wisely in multiple myeloma
